Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Research & Development Industry 2013/2014 Trends and Projections
  • USA - English


News provided by

Avomeen

Dec 18, 2013, 10:00 ET

Share this article

Share toX

Share this article

Share toX


(PRWEB) December 18, 2013 -- End of the year reports show that, overall, 2013 research and development (R&D) expenditures have stayed relatively flat over the year. In 2014, however, the R&D industry is forecasted to see some growth, although there is much discussion regarding the economic and government budget implication for the coming year. The expected growth is primarily indicated by a past increase and future expectation for private sector R&D spending.

In part investment is due to company size and available resources, while the primary priority of how to invest funding is tied to internal goals.

Post this

In total R&D funding for 2014 is projected to increase 3.2 percent in the United States. This would make the gross annual spending amount $465 billion. The percentages below are from Battelle and R&D Magazine’s report of projected spending according to “performer” type. Industry funding is by far the largest source of R&D funding at 71 percent, with academic research following second at only 13 percent.

Industry research is anticipated to increase by 3.8 percent next year to amount to greater than $330 billion. Within this, two industries of interest for 2014 are life sciences R&D and chemical materials. The life sciences Industry is expected to increase 2.2 percent in the coming year primarily due to biopharmaceutical innovation and medical device manufacturers. The chemical and advanced materials industry is projected to grow by 3.6 percent, continuing the steady growth from $10.7 billion in 2011 to an assumed $12.2 billion for 2014.

IBISWorld recently published a similar research report, emphasizing the impact and importance of privately funded research. The report, published December 8th, 2013 included a statement from Industry Analyst Jeremy Edwards who said, “Historically, government money has been devoted to basic research, or research without a specific goal, but private and corporate money is often devoted to experimental and developmental research that builds upon an existing idea that has already been developed by basic research.” It went on to note an increase in corporate R&D investment over the last five years, stating that the desire to acquire a competitive edge is the source of this ramp up. Due to this, IBISWorld projects that private funding and competitive product oriented research will continue to increase the yearly industry revenue at an annualized rate of 3.8 percent over the next five years.

R&D Magazine projected that in 2014 two of the primary changes in funding would be growth in life science as well as chemical and advanced materials industries. While IBISWorld pointed to competition as the underlying motivation for investment, R&D Magazine’s research acknowledged many factors as influention in R&D funding choices, noting that it varies greatly across individual chemical firms. In part investment is due to company size and available resources, while the primary priority of how to invest funding is tied to internal goals. The agenda for large, multinational firms relies primarily on developing materials for future use. Product focused firms perform research and development based on end-use, while small firms are commonly driven by customer demand.

A survey performed by Battelle and R&D Magazine revealed that 76% of firms in the chemical and advanced material sector place in-house development as their primary source of innovation. The survey also reported company’s hierarchy of how they measure the success of R&D activities.

Domestic corporations noted publications as the number one measurement of success followed by patents, product quality, and productivity respectively. Multinational corporations, on the other hand, cited new products as their primary measurement followed by patents, profitability, and publications.

Avomeen Analytical Services reviewed all findings from Battelle and R&D Magazine’s report as well as IBISWorld , specifically the claims that product focused, corporately funded research will be fundamental in changing the landscape of R&D investments. As an independent research facility, Avomeen’s services are primarily used to investigate formulations and either improve upon products currently in the market or create brand new custom formulations for individuals and corporations. From their experience Avomeen affirmed that competitive product design to create new products, acquire patents and increase profitability is indeed the common core motivation for companies who come to them for research and design services. They also remarked that it makes sense to see an ongoing rise in the chemical and advanced materials industry as this feeds innovation across most industries, including consumer products. When asked his opinion on where industry R&D is headed, Shri Thanedar, Ph.D. of Avomeen Analytical Services said, “There will never be a time when research and development becomes unnecessary. What we do is fundamental for continued improvement to the quality and accessibility of pharmaceuticals, consumer products, medical devices and more. For this reason, no matter the economic downturns or global economy, research and design will continually have a strong investment base.”

To read more about Avomeen’s customized research and development services visit their website at http://www.avomeen.com. Or, call 900.830.5450 to speak with a Ph.D. consultant over the phone.

Sarah Carroll, Avomeen, http://www.Avomeen.com, +1 8009305450 Ext: 121, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.